CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment

Detalles Bibliográficos
Autores principales: Shahzad, Faizan, Ur Rehman, Mohammad Ebad, Basit, Jawad, Saeed, Sajeel, Abbas, Khawar, Farhan, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574705/
https://www.ncbi.nlm.nih.gov/pubmed/36263082
http://dx.doi.org/10.1016/j.amsu.2022.104784
_version_ 1784811159666294784
author Shahzad, Faizan
Ur Rehman, Mohammad Ebad
Basit, Jawad
Saeed, Sajeel
Abbas, Khawar
Farhan, Muhammad
author_facet Shahzad, Faizan
Ur Rehman, Mohammad Ebad
Basit, Jawad
Saeed, Sajeel
Abbas, Khawar
Farhan, Muhammad
author_sort Shahzad, Faizan
collection PubMed
description
format Online
Article
Text
id pubmed-9574705
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95747052022-10-18 CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment Shahzad, Faizan Ur Rehman, Mohammad Ebad Basit, Jawad Saeed, Sajeel Abbas, Khawar Farhan, Muhammad Ann Med Surg (Lond) Correspondence Elsevier 2022-09-28 /pmc/articles/PMC9574705/ /pubmed/36263082 http://dx.doi.org/10.1016/j.amsu.2022.104784 Text en © 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correspondence
Shahzad, Faizan
Ur Rehman, Mohammad Ebad
Basit, Jawad
Saeed, Sajeel
Abbas, Khawar
Farhan, Muhammad
CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
title CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
title_full CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
title_fullStr CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
title_full_unstemmed CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
title_short CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
title_sort crispr/cas9 gene editing: a new hope for transthyretin amyloidosis treatment
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574705/
https://www.ncbi.nlm.nih.gov/pubmed/36263082
http://dx.doi.org/10.1016/j.amsu.2022.104784
work_keys_str_mv AT shahzadfaizan crisprcas9geneeditinganewhopefortransthyretinamyloidosistreatment
AT urrehmanmohammadebad crisprcas9geneeditinganewhopefortransthyretinamyloidosistreatment
AT basitjawad crisprcas9geneeditinganewhopefortransthyretinamyloidosistreatment
AT saeedsajeel crisprcas9geneeditinganewhopefortransthyretinamyloidosistreatment
AT abbaskhawar crisprcas9geneeditinganewhopefortransthyretinamyloidosistreatment
AT farhanmuhammad crisprcas9geneeditinganewhopefortransthyretinamyloidosistreatment

Ejemplares similares